Efficacy and Safety of Neoadjuvant TQB2102 in Locally Advanced or Early Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: A Randomized, Open-Label, Multicenter, Phase II Trial
新辅助TQB2102治疗局部晚期或早期人表皮生长因子受体2阳性乳腺癌的疗效和安全性:一项随机、开放标签、多中心II期试验
期刊:Journal of Clinical Oncology
影响因子:41.9
doi:10.1200/JCO-25-01153
Li, Jun-Jie; Zhang, Wen-Juan; Zeng, Xiao-Hua; Zhang, Qing-Yuan; Chen, Li; Wu, Jiong; Liu, Guang-Yu; Wang, Zhi-Hong; Hu, Xiao-Bo; Hu, Yan-Yan; Li, Zhen-Ling; Shao, Zhi-Ming